Skip to search.
 TSX Up 0.16% TSX Ventures Down 0.30%

Pluristem Therapeutics, Inc. (PSTI)

-NasdaqCM
1.55 Down 0.05(3.13%) Sep 29, 3:59PM EDT
Prev Close:1.60
Open:1.60
Bid:1.00 x 1000
Ask:1.79 x 1000
1y Target Est:3.25
Beta:0.202786
Earnings Date:Nov 7 - Nov 11 (Est.)
Day's Range:1.55 - 1.60
52wk Range:0.71 - 1.86
Volume:146,605
Avg Vol (3m):155,183
Market Cap:125.12M
P/E (ttm):N/A
EPS (ttm):-0.29
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
PSTIDown 3.13%125.12M
ACTC 0.00%N/A
OSIRDown 2.69%161.93M
ASTM 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):45.37
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-17) :-0.30
Quarterly EPS Est (Sep-16) :-0.08
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Pluristem Therapeutics Inc., through its subsidiary, Pluristem Ltd., operates as a bio-therapeutics company in Israel. The company focuses on the research, development, clinical trials, and manufacture of cell therapeutics products and related tec... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback